dupilumab
regeneron,sanofi
['eoe kids', 'dupilumab']
#mirnachehade from presents now at #ddw2023 dupilumab ( ) results from ages 1-11 in eoe kids phase 1 16wk induction trial. achieved primary and secondary endpoints (high dose presented, but low dose reported to also work) great news for kids with #eoe! 
Pediatric GI specializing in Inflammatory Bowel Disease (UC/CD) • Researcher of IBD Precision/Prevention • Patient w/ UC • Tweets my own